• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Efficacy of multiple-dose halofantrine in treatment of chloroquine-resistant falciparum malaria in children in Kenya.

作者信息

Watkins W M, Oloo J A, Lury J D, Mosoba M, Kariuki D, Mjomba M, Koech D K, Gilles H M

机构信息

Biomedical Sciences Research Centre, Kenya Medical Research Institute (KEMRI), Nairobi.

出版信息

Lancet. 1988 Jul 30;2(8605):247-50. doi: 10.1016/s0140-6736(88)92538-x.

DOI:10.1016/s0140-6736(88)92538-x
PMID:2899237
Abstract

Halofantrine hydrochloride given to 46 Kenyan children with falciparum malaria at 10 mg/kg for two doses, and to 60 other children at 8 mg/kg for three doses, resulted in rapid parasite clearance, mean parasite clearance times being 45.4 h and 54.8 h, respectively. In-vitro chemosensitivity tests showed that most infections were due to chloroquine-resistant parasites, and that parasite maturation was inhibited by considerably lower concentrations of halofantrine than of chloroquine.

摘要

相似文献

1
Efficacy of multiple-dose halofantrine in treatment of chloroquine-resistant falciparum malaria in children in Kenya.
Lancet. 1988 Jul 30;2(8605):247-50. doi: 10.1016/s0140-6736(88)92538-x.
2
Clinical trials with halofantrine hydrochloride in Malawi.
Lancet. 1988 Jul 30;2(8605):250-2. doi: 10.1016/s0140-6736(88)92539-1.
3
Comparative efficacy of chloroquine plus chlorpheniramine and halofantrine in acute uncomplicated falciparum malaria in Nigerian children.氯喹加氯苯那敏与卤泛群治疗尼日利亚儿童急性非复杂性恶性疟的疗效比较
Trans R Soc Trop Med Hyg. 1998 Jul-Aug;92(4):441-5. doi: 10.1016/s0035-9203(98)91084-7.
4
Halofantrine in the treatment of malaria.
Lancet. 1989 Sep 2;2(8662):537-8.
5
High dose chloroquine versus micronized halofantrine in chloroquine-resistant Plasmodium falciparum malaria.
J Antimicrob Chemother. 1994 Apr;33(4):871-5. doi: 10.1093/jac/33.4.871.
6
Halofantrine hydrochloride--efficacy and safety in children with acute malaria.
J Pak Med Assoc. 1991 Jan;41(1):8-10.
7
Halofantrine pharmacokinetics in Kenyan children with non-severe and severe malaria.卤泛群在肯尼亚非重症和重症疟疾儿童中的药代动力学
Br J Clin Pharmacol. 1995 Mar;39(3):283-7. doi: 10.1111/j.1365-2125.1995.tb04450.x.
8
[Halofantrine hydrochloride in the treatment of Plasmodium falciparum malaria in a region of resistance. Analysis of 54 pediatric cases].
Ann Soc Belg Med Trop. 1990 Mar;70(1):25-32.
9
Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria.卤泛群与甲氟喹治疗多重耐药恶性疟的比较
Lancet. 1993 Apr 24;341(8852):1044-9. doi: 10.1016/0140-6736(93)92409-m.
10
Comparison of micronized halofantrine with chloroquine-antibiotic combinations for treating Plasmodium falciparum malaria in adults from Gabon.微粉化卤泛群与氯喹-抗生素联合用药治疗加蓬成年人恶性疟原虫疟疾的比较。
Am J Trop Med Hyg. 1994 Jun;50(6):790-5. doi: 10.4269/ajtmh.1994.50.790.

引用本文的文献

1
Effect of kolanut on the pharmacokinetics of the antimalarial drug halofantrine.
Eur J Clin Pharmacol. 2008 Jan;64(1):77-81. doi: 10.1007/s00228-007-0387-0. Epub 2007 Oct 20.
2
Halofantrine efficacy in non-immune children with imported acute Plasmodium falciparum malaria Infection.
Eur J Pediatr. 2004 Jan;163(1):22-4. doi: 10.1007/s00431-003-1316-6. Epub 2003 Nov 28.
3
Efficacy of micronized halofantrine in semi-immune patients with acute uncomplicated falciparum malaria in Cameroon.微粒化卤泛群在喀麦隆急性非复杂性恶性疟半免疫患者中的疗效。
Antimicrob Agents Chemother. 1993 Sep;37(9):1955-7. doi: 10.1128/AAC.37.9.1955.
4
Clinical pharmacokinetics in the treatment of tropical diseases. Some applications and limitations.热带病治疗中的临床药代动力学。一些应用与局限。
Clin Pharmacokinet. 1994 Aug;27(2):150-65. doi: 10.2165/00003088-199427020-00006.
5
Clinical pharmacokinetics of halofantrine.卤泛群的临床药代动力学
Clin Pharmacokinet. 1994 Aug;27(2):104-19. doi: 10.2165/00003088-199427020-00003.
6
New antimalarials. A risk-benefit analysis.新型抗疟药。风险效益分析。
Drug Saf. 1995 Apr;12(4):264-73. doi: 10.2165/00002018-199512040-00006.
7
Halofantrine pharmacokinetics in Kenyan children with non-severe and severe malaria.卤泛群在肯尼亚非重症和重症疟疾儿童中的药代动力学
Br J Clin Pharmacol. 1995 Mar;39(3):283-7. doi: 10.1111/j.1365-2125.1995.tb04450.x.
8
Pharmacokinetics of halofantrine in man: effects of food and dose size.卤泛群在人体中的药代动力学:食物和剂量大小的影响。
Br J Clin Pharmacol. 1989 Jul;28(1):71-7. doi: 10.1111/j.1365-2125.1989.tb03507.x.
9
Pharmacokinetics of halofantrine in Thai patients with acute uncomplicated falciparum malaria.卤泛群在泰国急性单纯性恶性疟患者中的药代动力学
Br J Clin Pharmacol. 1991 Apr;31(4):484-7. doi: 10.1111/j.1365-2125.1991.tb05567.x.
10
Antimalarial pharmacokinetics and treatment regimens.抗疟药的药代动力学与治疗方案。
Br J Clin Pharmacol. 1992 Jul;34(1):1-10. doi: 10.1111/j.1365-2125.1992.tb04100.x.